Mild to moderate endometriosis

Indication for Medroxyprogesterone

Population group: Suitable for women, only adults (18 - 65 years old)

For this indication, competent medicine agencies globally authorize below treatments:

30 mg in 3 divided dosess daily

Route of admnistration


Defined daily dose

30 - 30 mg

Dosage regimen

From 10 To 10 mg 3 time(s) per day every day for 90 day(s)

Detailed description

Beginning on the first day of the menstrual cycle, 10 mg three times a day for 90 consecutive days. Breakthrough bleeding, which is self-limiting, may occur. No additional hormonal therapy is recommended for the management of this bleeding.

Active ingredient

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.

Read more about Medroxyprogesterone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner